















BP	Category	 Systolic	mm	Hg	 	 Diastolic	mm	Hg	
Normal	 Less	than	120	 And	 Less	than	80	















Category	 Systolic	mm	Hg	 	 Diastolic	mm	Hg	
Normal	 Less	than	120	 And	 Less	than	80	





































Repetition:	 1	 2	 3	 4	 5	 1	 2	 3	
Equipment:	
IQ	 IQ-TY	 IQ-TY	 IQ-TY	 IQ-TY	 IQ-TY	 IQ-PR	 IQ-PR	 IQ-PR	
OM	 	 	 	 	 	 OM-PR	 OM-PR	 OM-PR	











Variable	 N	 Mean	 SE	
Mean	
SD	 Minimum	 Q1	 Median	 Q3	 Maximum	
Age	
(years)	
39	 27.5	 1.7	 10.4	 18.0	 21.0	 32.0	 33.0	 59.0	









F	 21	 53.8	 0	 36	 92.3	 <25	 23	 59.0	
M	 18	 46.2	 1	 3	 7.7	 25-30	 13	 33.3	
Total	 39	 	 Total	 39	 	 Total	 39	 		The	descriptive	statistics	for	the	systolic	(SYS)	and	diastolic	(DIA)	BP	measurement	for	each	type	of	equipment	is	displayed	in	Tables	6	and	7.		The	systolic	BP	endpoint	had	a	highest	to	lowest	value	recorded,	based	on	equipment	type.		Looking	at	equipment	only,	the	ranking	of	the	systolic	BP	endpoint	had	the	highest	value	with	OM-PR,	followed	by	IQ-PR.		The	lowest	value	was	MA-PR.		The	comparison	of	all	the	systolic	endpoint	data,	based	on	equipment	type	were	all	statistically	significant	(P<0.001).	MA-PR	has	38	instead	of	39	data	points	because	there	was	an	outlier	at	82.7	mmHg.	The	diastolic	BP	endpoint,	had	a	similar	highest	to	lowest	value	range	recorded,	based	on	equipment	type.		The	ranking	of	the	diastolic	BP	endpoint	had	the	highest	value	recorded	with	IQ-PR	followed	by	OM-PR.		The	lowest	value	was	MA-PR.	The	comparison	of	all	the	diastolic	BP	endpoint	data,	based	on	equipment	type,	produced	no	statistical	difference	between	diastolic	BP.		
Table	6:	Descriptive	Statistics	for	Systolic	BP	measurement	of	IQ-TY,	IQ-PR,	OM-PR,	and	MA-PR	
Variable	 N	 Mean	 SE	
Mean	
SD	 Minimum	 Q1	 Median	 Q3	 Maximum	
IQ-TY	
Systolic	
39	 123.7	 1.8	 11.5	 106.2	 116.2	 120.8	 131.6	 153.8	
IQ-PR	
Systolic	
39	 114.8	 1.6	 9.9	 95.3	 108.7	 111.7	 12.0	 143.7	
OM-PR	
Systolic	
39	 118.3	 2.0	 12.6	 97.3	 108.7	 116.7	 125.3	 150.0	
MA-PR	
Systolic	






Variable	 N	 Mean	 SE	
Mean	
SD	 Minimum	 Q1	 Median	 Q3	 Maximum	
IQ-TY	
Diastolic	
39	 79.6	 1.6	 9.8	 57.8	 73.2	 76.4	 86.8	 101.8	
IQ-PR	
Diastolic	
39	 71.2	 1.3	 8.1	 55.0	 65.0	 72.0	 77.0	 87.0	
OM-PR	
Diastolic	
39	 71.1	 1.3	 8.1	 58.3	 65.3	 70.7	 77.3	 88.7	




















































































Systolic	endpoints	 Mean	IQ-TY	 Mean	IQ-PR	 Mean	OM-PR	
Mean	IQ-PR	 R=0.90;	p<	0.05	 	 	
Mean	OM-PR	 R=	0.78;p<	0.05	 R=	0.9;	p<	0.05	 	




Diastolic	endpoints	 Mean	IQ-TY	 Mean	IQ-PR	 Mean	OM-PR	
Mean	IQ-PR	 R=0.81;	p<	0.05	 	 	
Mean	OM-PR	 R=	0.86;p<	0.05	 R=	0.84;	p<	0.05	 	








































normal	 elevated	 stage	1	hyper	 stage	2	hyper	
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The	same	additional	measures	used	to	compare	the	equipment	were	also	useful	to	compare	the	different	conditions.	Referring	to	the	top	row	in	Figure	2,	IQ-TY	produced	systolic	BP	measurements	that	were	higher	than	the	other	methods	for	nearly	all	the	participants.	In	Tables	8	and	9	it	can	be	noted	that	IQ-TY	had	a	high	significant	correlation	between	all	the	equipment	for	both	systolic	and	diastolic	BP	measurements.	The	lowest	correlation	was	0.8.	In	table	9	the	measurement	variance	for	IQ-TY	can	be	seen	as	6.58	mmHg	for	systolic	and	4.59	mmHg	for	diastolic.	The	systolic	was	higher	while	the	diastolic	had	a	lower	measurement	variance	compared	to	IQ-PR.	When	using	IQ-TY	to	classify	participants	in	hypertension	stage,	the	data	generated	classified	participants	as	either	normal	(N=15),	elevated	(N=16),	stage	1	hypertension	(N=7),	or	stage	2	hypertension	(N=1)	as	seen	in	Figure	5.	IQ-TY	classified	the	most	people	as	pre-hypertensive,	stage	1	hypertension,	and	was	the	only	method	to	have	an	individual	as	stage	2	hypertension	compared	to	all	the	other	equipment.			 Additional	data	analyses	were	completed	to	determine	the	strength	of	relationship	between	the	difference	of	IQ-PR	and	IQ-TY	based	on	gender,	BMI,	BP	medication,	or	age.		None	of	these	additional	comparisons	proved	to	be	statistically	significant.	When	considering	that	participants	were	allowed	to	talk	during	the	BP	data	collection,	this	condition	did	not	prove	to	significantly	increase	systolic	BP.		The	average	increase	in	the	systolic	BP	endpoint,	due	to	talking,	was	only	0.83	mm	Hg	with	a	standard	error	of	1.11	(p=0.46).	However	allowing	participants	to	talk	during	the	BP	data	collection	did	prove	to	significantly	increase	the	diastolic	BP	endpoint	by	an	average	increase	of	1.88	mm	Hg	with	a	standard	error	of	0.7	(p=0.01).			 An	intraclass	correlation	coefficient	(ICC)	was	used	to	determine	the	reproducibility	of	the	data	obtained;	for	systolic	it	was	0.87	and	for	diastolic	it	was	0.81.						
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Discussion		This	cohort	was	recruited	from	a	medical	campus	of	college-aged	students	and	employees	of	various	ages	and	backgrounds.	With	54%	of	the	participants	being	female,	mean	age	of	27.5	yrs,	and	average	BMI	of	24.6	this	cohort	of	participants	appears	to	have	a	lower	BMI	in	comparison	to	the	US	population	average	BMI,	which	is	26.5.12	Along	with	a	healthier	body	composition,	this	cohort	of	participants	also	had	lower	hypertension	trends	than	the	US	population.	The	US	trend,	under	the	old	guidelines	(BP	140/90	or	above)	for	hypertension	among	those	20	years	and	older	was	30%,	however	in	the	survey,	most	in	the	cohort	were	older.13			In	that	same	survey	group,	those	20-44	years	of	age,	which	is	more	comparable	to	the	current	pilot	sample	of	participants	since	the	mean	age	was	27.5,	had	a	rate	of	hypertension	of	12%.13	This	was	based	on	the	old	guidelines,	so	this	number	would	be	even	higher	if	the	new	guidelines	were	used.	Basing	hypertension	purely	on	a	BP	measurement	of	140/90	or	higher	(the	old	guidelines	so	an	even	comparison	can	be	made),	no	participant	was	hypertensive	when	following	protocol	on	any	equipment.	The	US	trend	for	hypertension	also	indicates	33%	of	those	20	years	and	older	are	at	risk	for	hypertension.13	This	risk	for	younger	people	is	alarming	and	careful	detection	of	an	elevated	BP	is	a	means	towards	addressing	the	tendency	for	developing	cardiovascular	disease.		 Blood	pressure	is	a	vital	sign	taken	by	providers	in	outpatient	and	inpatient	facilities,	serving	as	an	indicator	for	numerous	diseases	from	the	common	cold	to	serious	cardiovascular	disease.	Elevated	blood	pressure	itself	has	the	potential	to	lead	to	dangerous	conditions	such	as	stroke	or	heart	attack.	The	significant	discrepancy	between	equipment	and	protocol	should	underscore	the	need	for	consistency	and	accuracy	when	this	critical	vital	sign	is	being	measured.			 First,	taking	the	equipment	into	consideration,	in	the	past	several	decades	there	has	been	a	trend	away	from	manual	and	towards	automated	BP	measurement.	With	this	transition	came	resistance	due	to	not	knowing	how	to	handle	potential	discrepancies	in	the	biometric	data.	Was	the	machine	or	the	provider	the	source	of	inaccuracy?	Based	on	the	results	of	the	current	study,	there	
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was	a	significant	difference	between	devices	for	the	systolic	BP,	but	not	for	the	diastolic	BP.	The	home	unit	had	the	highest	BP	measurements,	while	manual	had	the	lowest.	Due	to	the	ordered	(OM-PR>IQ-PR>MA-PR)	significant	difference	for	systolic	BP,	hypothesis	1	has	to	be	rejected.	Literature	produced	from	the	clinical	setting	found	slightly	different	results.		Myers	and	colleagues	found	automated	units	to	produce	significantly	lower	measurements	than	manual	methods	and	concluded	that	automated	units	have	higher	quality	and	accuracy	due	to	the	ability	to	reduce	digit	preference	and	white	coat	response,	both	of	which	were	not	studied	in	the	current	study.14	Digit	preference	is	the	tendency	to	round	a	number	so	the	one’s	digit	is	a	0	or	a	5	when	recording	manual	BP.	White	coat	response	is	the	tendency	for	an	individual’s	BP	to	raise	when	it	is	measured	in	a	clinical	setting.	Mirdamadi,	et	al.,	as	well	as	Eteban	et	al.	also	found	manual	BP	measurement	to	be	significantly	higher	than	automated	measurement.15	A	separate	study	by	executed	by	Mansoor	and	colleagues,	within	the	emergency	department,	concluded	that	automated	units	produce	readings	that	are	too	varied	to	be	considered	reliable	for	use	in	the	ED.16	The	spectrum	of	information	found	in	the	present	study	as	well	as	the	literature	makes	it	apparent	that	further	investigation	of	the	differences	between	manual	and	automated	units	is	needed.	It	is	important	to	keep	in	mind	that	this	study	did	not	account	for	white	coat	effect,	which	can	be	a	major	benefit	of	automated	units.		All	the	variation	raises	the	important	question	of	what	is	the	most	accurate	means	to	measure	the	patient’s	blood	pressure.		 Next,	based	on	comparing	the	two	measurement	protocols,	condition	(protocol)	appeared	to	be	a	more	influential	factor	than	equipment,	though	this	was	only	tested	with	one	of	the	devices.	The	lack	of	protocol	produced	significantly	higher	systolic	and	diastolic	BP	measurements	than	the	protocol	measurements.	This	is	evident	in	the	higher	systolic	end	point	for	IQ-TY	(123.7	mmHg)	compared	to	IQ-PR	(114.8	mmHg),	as	well	as	the	higher	diastolic	end	point	of	IQ-TY,	79.6	mmHg,	compared	to	IQ-PR,	71.15	mmHg.	The	effect	of	a	lax	protocol	can	also	be	easily	visualized	in	figures	2	and	3,	which	show	nearly	all	the	data	points	clustered	above	the	regression	line	for	the	graphs	
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involving	IQ-TY’s.	The	dramatic	increase	in	BP	for	IQ-TY	allows	hypothesis	2	to	be	confirmed.		By	examining	the	ranges	of	the	axes	in	Figures	2	and	3	it	is	obvious	that	lack	of	protocol	is	much	more	influential	than	equipment	(though	this	statement	is	limited	by	the	fact	that	the	effect	of	protocol	was	only	tested	using	the	IQvitals	device.	In	order	to	obtain	the	best	BP	measurement	to	create	a	patient	trend,	it	is	imperative	that	protocol	is	consistently	followed.	That	way	when	there	is	an	increase	or	decrease	in	BP,	the	provider	can	assume	it	is	due	to	a	physiological	change.	There	is	already	conflict	over	natural	variation	in	BP	and	whether	episodic	or	maximum	BP	is	meaningful.	The	natural	variation	in	BP	is	used	to	assess	cardiovascular	risk.	Dr.	Rothwell	discusses	this	variation	in	BP	and	how	it	is	used	in	the	clinical	setting	to	diagnosis	diseases.	Rothwell	also	warns	against	relying	too	much	on	a	single	measurement	as	there	are	natural	fluctuations	depending	on	surrounding	environment,	but	variation	in	BP,	especially	increases,	can	be	signs	of	atrial	disease	and/or	organ	damage.17	If	this	perceived	“natural”	is	merely	just	an	inconsistency	in	protocol	used,	then	the	diagnosis	and	treatment	could	be	wrong	and	detrimental	to	the	patient.		 An	interesting	discovery	when	comparing	IQ-TY	and	IQ-PR	is	that	the	mean	increase	for	the	systolic	BP	is	only	9	mmHg	and	increase	in	diastolic	BP	is	only	8	mmHg.	The	difference	between	the	two	measurements	is	the	participant	had	their	feet	elevated	from	the	ground	(+5-10	mmHg),	back	unsupported	(+5-10	mmHg),	arm	unsupported	(+10	mmHg),	non-resting	for	3-5	minutes	(+10-20	mmHg),	and	potentially	talking	(+10-15mmHg)	in	IQ-TY.9	If	the	different	variables	were	cumulative,	then	they	would	add	up	to	an	increase	of	at	least	30	mmHg.	The	increase	seen	in	this	pilot	study	with	condition	TY	was	less	than	10	mmHg.	This	confirms	that	the	variables	necessary	to	follow	protocol	and	obtain	a	proper	BP	are	not	additive,	consistent	with	the	literature.9	Therefore	the	patient	could	have	the	same	elevated	BP	if	1	or	5	variables	of	the	protocol	are	not	followed.	Based	on	this	information,	it	imperative	to	pay	attention	to	proper	BP	measurement	technique	because	one	misstep	could	cause	a	significant	difference.		
21 
 
	 One	of	the	common	aspects	of	protocol	that	is	forgotten	is	waiting	3-5	minutes	to	allow	the	patient	to	rest	before	a	BP	is	taken.	The	significant	difference	between	the	first	and	last	BP	measurement	in	IQ-TY	shows	that	the	effect	of	ignoring	rest	time	is	higher	BP	measurement.	Based	on	a	study	done	by	Ray	et	al.	the	typical	patient	spends	84	minutes	in	the	clinic	per	visit.18	This	gives	the	facility	plenty	of	opportunity	to	find	3-5	minutes	to	allow	the	patient	to	sit	down	and	rest	before	BP	is	measured.	The	current	healthcare	push	for	speed	and	efficiency	may	make	this	more	difficult,	but	it	is	definitely	possible	as	the	visit	is	substantially	longer	than	5	minutes.	It	is	not	worth	rushing	through	a	visit	and	obtaining	improper	measurements	on	the	patient	because	these	data	points	are	intended	to	aid	in	the	diagnosis	and	care	of	the	patient.		Potentially	erroneous	measurements	could	result	in	the	inability	to	provide	the	best	patient	care,	which	should	be	the	primary	goal	of	providers.		 Revisiting	hypothesis	1,	the	differences	between	equipment,	it	is	important	to	consider	how	the	indirect	measure	of	BP	is	used	in	the	medical	management	of	the	patient.	The	trend	a	patient’s	BP	measurements	can	be	a	sign	to	detect	various	diseases.	Although	trend	data	was	not	obtained	in	this	pilot	study,	the	strong	association	between	equipment	as	displayed	in	tables	8	and	9	can	point	to	how	the	various	pieces	of	equipment	can	be	used.	For	example,	say	a	patient	who	was	recording	their	BP	at	home	with	an	Omron	home	automated	unit	came	into	their	primary	care	visit	and	told	the	provider	that	their	recent	BP	readings	were	high.	With	this	information	the	provider	assume	that	the	BP	measurement	in	the	office	will	also	be	high,	though	the	provider	cannot	assume	the	BP	measurements	will	produce	exactly	the	same	value.	Along	with	the	strong	association,	the	two	pieces	of	equipment	normally	used	in	the	clinical	setting,	MA	and	IQ,	only	had	a	mean	difference	of	3	mmHg	for	systolic	BP.	Since	hypertension	categories	change	every	10	mmHg,	the	difference	of	3	mmHg	is	only	a	movement	within	a	single	category.	So	based	on	the	strong	association	and	minimal	difference	between	clinical	devices,	the	different	pieces	of	equipment	all	still	have	value	in	the	clinical	setting.	
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Revisiting	hypothesis	2,	when	protocol	is	not	followed,	it	is	important	to	think	about	how	BP	measurements	are	used	to	categorize	patients.	The	categorization	allows	providers	to	determine	the	best	treatment	to	reduce	hypertension	at	any	stage	and	lower	the	risk	for	potential	cardiovascular	disease.	The	AHA	worked	together	with	the	American	College	of	Cardiology	(ACC)	to	provide	revised	guidelines	for	hypertension	classification	and	management	in	the	fall	of	2017.4	Referring	to	Figure	5,	the	present	cohort	is	profiled	using	the	revised	classifications	and	demonstrates	how	the	data,	generated	by	the	equipment	in	the	context	of	condition	(‘protocol’),	categorized	the	participants.	It	is	clearly	visible	IQ-TY	categorized	more	participants	as	having	elevated	BP,	as	well	as	stage	1	and	stage	2	hypertension	than	all	the	other	conditions	where	protocol	was	followed.	Further,	when	comparing	IQ-TY	to	IQ-PR,	there	was	a	difference	of	8.9	mmHg	for	systolic	and	8.4	mmHg	for	diastolic,	which	is	nearly	the	difference	between	most	hypertension	categories.	Due	to	the	result	suggesting	that	the	lack	of	following	protocol	leads	to	movement	from	a	lower	to	a	higher	hypertension	category,	protocol	must	be	followed	whenever	BP	measurements	are	taken.			 The	revised	BP	classification	presents	the	perfect	opportunity	for	practices	to	revisit	the	way	BP	is	acquired.	Hypertension	is	definitely	an	issue,	as	a	third	of	the	US	population	was	deemed	to	be	hypertensive,	under	the	previous	AHA	categories.			It	is	possible	that	around	half	of	the	US	population	will	now	be	considered	hypertensive,	based	on	the	revised	classification	system.7	Hypertension	is	a	major	issue	and	should	be	treated	when	diagnosed,	but	it	is	imperative	that	those	at	risk	are	first	properly	diagnosed	and	then	properly	treated.	Anti-hypertensive	medications	are	the	most	common	method	to	treat	hypertension,	yet	they	have	many	side	effects.	Individuals	who	truly	need	it	should	be	the	only	ones	taking	medication.		Additional	methods	for	treating	elevated	BP,	such	as	lifestyle	changes,	have	far	fewer	potential	side	effects	and	many	more	potential	benefits.	As	the	AHA	guidelines	have	been	revised	and	BP	thresholds	lowered,	the	number	of	patients	being	placed	on	medication	is	likely.			This	study	would	suggest	that	lack	of	adherence	to	protocol	
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significantly	increases	BP	measurement;	therefore	it	is	imperative	that	the	AHA	protocol	is	followed	and	the	patient’s	BP	measurement	is	not	artificially	elevated	due	to	a	protocol	error.	The	BP	measurement	should	truly	reflect	the	diagnostic	condition	of	the	patient.	The	goal	of	providers	is	to	provide	the	best	patient	care,	and	in	order	to	do	this,	it	is	important	obtain	the	best	data	for	making	critical	diagnostic	decisions.			 It	is	possible,	based	on	the	results	of	this	pilot	study,	that	changing	procedure	to	improve	protocol	adherence	would	likely	have	more	effect	on	BP	measurements	than	a	change	in	equipment	(at	least	for	the	three	devices	used	in	this	study).	So	when	an	equipment	change	is	considered	as	a	means	to	change	workflow,	the	workflow	change	affecting	the	condition	in	which	BP	is	being	measured,	not	the	equipment,	is	likely	the	main	contributor	to	the	fluctuating	BP	measurements.			
Limitations	There	were	several	limitation	with	this	study.	One	of	the	major	ones	was	the	design	of	this	study	as	pre-experimental	and	therefore	there	are	threats	to	internal	and	external	validity.		The	sample	of	participants	was	a	purposive	group	of	volunteers	so	these	results	are	unique	to	the	group	and	cannot	be	translated	to	a	larger	population.			The	fact	that	there	was	only	one	person	taking	BPs	for	the	MA-PR	measurements	is	perhaps	not	clinically	translatable.	One	of	the	major	downfalls	with	manual	measurements	is	that	different	people	take	them	and	they	may	hear	things	differently	or	be	more	or	less	skilled	at	taking	BP,	which	may	lead	to	a	larger	variation	in	measurements.	The	individual	taking	the	MA-PR	measures	in	the	current	study	was	not	a	physician,	nor	were	the	measurements	made	in	a	healthcare	setting,	so	the	white	coat	response	was	not	present.	These	pitfalls	of	manual	readings	could	not	be	address	in	this	study,	but	pose	an	interesting	question	for	a	future	study	to	investigate.		Another	limitation	was	that	there	was	only	a	limited	amount	of	time	with	the	participant,	so	the	number	and	combination	of	conditions	of	measurements	had	to	be	curtailed.	This	prevented	the	
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opportunity	to	fully	cross	device	and	condition,	which	would	have	afforded	the	opportunity	to	test	for	interactions	between	device	and	condition,	rather	than	examining	only	main	effects	of	condition	and	device.		Therefore	this	is	something	that	could	be	addressed	in	a	future	study.			 Finally,	most	of	the	participants	were	younger,	which	may	have	skewed	the	data,	since	many	were	healthy	young	adults	who	generally	have	limited	health	issues	or	elevated	BP.	A	future	study	could	expand	the	sample	and	try	to	get	a	much	more	diverse	participant	group.			 This	study	was	begun	at	the	time	that	the	AHA	released	an	amendment	to	their	diagnostic	thresholds	for	hypertension.		Therefore	these	pilot	results	were	timely	for	assessing	effects	of	equipment,	protocol,	and	resting	on	BP.	The	goal	of	this	pilot	work	was	to	provide	information	about	obtaining	BP	which	could	assist	providers,	improve	diagnostic	practice,	and	the	care	for	patients.			It	also	begins	a	very	important	discussion	on	the	potential	for	the	collecting	reliable	BP	data	that	can	assist	in	correctly	classifying	patients	based	on	the	new	AHA	hypertensive	guidelines.																			
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